Immunological memory is characterized by a more rapid and efficient response to previously encountered pathogens. Thereby, memory recall responses protect against infections that can otherwise cause disease or even death in immunologically naive hosts. Memory CD8 + T cells (T M ) are instrumental for the rapid detection and eradication of intracellular pathogens. Several subsets of T M have been identified based on their migration patterns, anatomical location, and functional specialization . Historically, memory T cells have been divided into central memory T cells (T CM ) and effector memory T cells (T EM ; Sallusto et al., 1999) . T CM home to secondary lymphoid organs, exhibit high proliferative capacity upon reencountering cognate antigen, and serve as a self-replenishing pool that gives rise to other memory T cell subsets (Graef et al., 2014) . Conversely, T EM do not express the homing receptors characteristic of T CM , recirculate through the body, and can provide immediate effector function (Sallusto et al., 1999) . Recently, tissue-resident memory T cells (T RM ) have been identified as an additional subset of memory T cells that does not recirculate, but persists at sites of previous infection, such as skin and mucosal tissues Park and Kupper, 2015) , as well as the brain (Wakim et al., 2010) . T RM from various organs, including the brain show overlapping transcriptional profiles with a core transcriptional signature , distinguishing them from circulating T M (Wakim et al., 2012; Mackay et al., 2013) . In most nonlymphoid tissues, T RM outnumber patrolling T EM and constitute the largest component of T cell memory (Steinert et al., 2015) . Their persistence in organs is mediated by specific adhesion molecules, such as CD103 (Integrin αE; Gebhardt et al., 2009; Casey et al., 2012; Mackay et al., 2013) and loss of tissue egress receptors from the cell surface (Skon et al., 2013; Mackay et al., 2015a) . Bona fide T RM have been described to express CD69, which antagonizes the tissue egress receptor sphingosine 1-phosphate receptor 1 (S1P1; Mackay et al., 2015a) . Surface expression of CD103 seems specific for T RM, but not all T RM express the molecule. Long-lived CD103 − T RM have been described in secondary lymphoid organs , in the gut (Bergsbaken and Bevan, 2015) , and in the female reproductive tract (Steinert et al., 2015) . CD103 expression has been associated with tissue retention (Wakim et al., 2010; Casey et al., 2012; Mackay et al., 2013) , epithelial localization (Gebhardt et al., 2009; Sheridan et al., 2014) and function (Wakim et al., 2010; Laidlaw et al., 2014; Bergsbaken and Bevan, 2015) , but it remains elusive whether CD103 expression is causally linked to these characteristics. The generation and maintenance of T RM is dependent on IL-7 and IL-15-mediated signals (Mackay et al., 2013; Adachi et al., 2015) , however, whether T RM undergo Tissue-resident memory T cells (T RM ) persist at sites of prior infection and have been shown to enhance pathogen clearance by recruiting circulating immune cells and providing bystander activation. Here, we characterize the functioning of brain-resident memory T cells (bT RM ) in an animal model of viral infection. bT RM were subject to spontaneous homeostatic proliferation and were largely refractory to systemic immune cell depletion. After viral reinfection in mice, bT RM rapidly acquired cytotoxic effector function and prevented fatal brain infection, even in the absence of circulating CD8 + memory T cells. Presentation of cognate antigen on MHC-I was essential for bT RM -mediated protective immunity, which involved perforin-and IFN-γ-dependent effector mechanisms. These findings identify bT RM as an organ-autonomous defense system serving as a paradigm for T RM functioning as a self-sufficient first line of adaptive immunity. Karin Steinbach, 1 homeostatic proliferation to maintain a stable population has so far not been demonstrated.
Brain-resident memory T cells represent an autonomous cytotoxic barrier to viral infection
T RM accelerate and improve pathogen clearance upon reinfection (Gebhardt et al., 2009; Jiang et al., 2012; Shin and Iwasaki, 2012; Wakim et al., 2012; Sheridan et al., 2014) , but the underlying mechanisms remain a subject of ongoing investigation. Reactivation of T RM by cognate antigen leads to the production of inflammatory cytokines, such as IFN-γ. Consequently, antiviral genes are induced and additional immune cells are rapidly recruited from the circulation (Schenkel et al., 2013 Ariotti et al., 2014) . The currently prevailing concept therefore suggests that T RM represent a tissue-restricted surveillance system with the capacity to alert circulating T M in case of reinfection (Carbone, 2015) . Conversely, a potential function of T RM as directly cytotoxic antiviral effectors, and thus as an autonomous immunological barrier to viral reinfection, has so far been mostly dismissed, owing to the small number of T RM , which persist after primary infection, although reports suggest a direct antiviral function of skin T RM Jiang et al., 2012; Mackay et al., 2015b) .
Here, we studied brain T RM (bT RM ) in established mouse models of viral CNS infection. Antiviral bT RM persisted in the CNS for prolonged periods of time, underwent homeostatic proliferation, and served as a potent cellular barrier of antigen-specific immunity, which achieved virus control independently of circulating T cells. Rapid bT RM -mediated virus clearance relied on IFN-γ expression and perforin-mediated cytotoxicity and protected mice from immunopathological CNS disease. Our findings suggest that bT RM can act as an organ-autonomous defense system of the CNS.
RES ULTS CD103
+ and CD103 − bT RM persist after cerebral viral infection and accelerate pathogen clearance during infection with a related virus To study the generation and function of bT RM , we infected mice intracerebrally (i.c.) with a genetically engineered, attenuated lymphocytic choriomeningitis virus (LCMV) variant (rLCMV; Pinschewer et al., 2003) . As previously shown (Pinschewer et al., 2010) , i.c. administered rLCMV rapidly drained to the periphery and triggered a potent peripheral antiviral CD8 + T cell response, which resolved the brain infection within ten days (Fig. 1 A) . Thereafter, T cell numbers in the brain contracted, but a population of T M persisted in stable number and frequency from 6 wk after infection onwards (Fig. 1, B and C). At that time point, most persisting T M cells expressed CD69, a prototypic T RM marker. CD69 + brain T M expressed high Bcl-2 levels, and many were Granzyme B-positive (59 ± 3%), whereas most of them were specific for the immunodominant LCMV epitope NP 396-404 (82 ± 5%). However, only about half of these cells (50 ± 10%) expressed CD103 ( Fig. 1 D and Fig. S1 ). Both CD103 + and CD103 − CD69 + T M subsets persisted in stable relative proportions over time (Fig. 1 E) . Analogously to the endogenous CD8 + T cell pool, both CD103 + and CD103 − brain T M subsets were found in adoptively transferred CD8 + TCR transgenic P14 or OT-1 cells, respectively, after i.c. infection with rLCMV variants encoding the respective cells' cognate epitopes (Fig. 1 F) . Furthermore, CD103
+ and CD103 − OT-1 brain T M were generated after intrathecal infection with a modified vaccinia virus (MVA; Rothhammer et al., 2014) expressing OVA (Fig. 1 G) . CD69 expression correlated with exclusion from staining with i.v. administered fluorescent antibody (Anderson et al., 2014; Fig. 1 H) and extravascular CD8 + T cells identified by immunostaining on brain sections expressed CD69 (95 ± 3%; n = 3 mice). Furthermore, most brain CD69 + T M cells were refractory to depletion by peripherally administered depleting anti-CD8 antibody (Fig. 1 I) . Altogether, this demonstrated that the vast majority of CD69 + T M cells in brain were bona fide T RM (from now on referred to as bT RM ).
To investigate the protective role of bT RM upon brain reinfection, we generated rLCMV memory mice by either i.v. or co-infection (i.c. + i.v.; Fig. 2 A) . Co-infection was used to assure similar generation of circulating T M . Indeed, both infection routes led to similar frequencies of D b -NP 396-404 LCMV-specific T M in peripheral blood (Fig. 2 B) . However, in contrast to bT RM generated upon i.c. infection, only limited numbers of T M cells were present in the brain after i.v. infection with rLCMV ( Fig. 2 , C and D). These latter cells were susceptible to depletion by peripherally administered anti-CD8a antibody (unpublished data) demonstrating that T M detectable in the brain after i.v. rLCMV infection are in equilibrium with the circulation and do not represent bona fide bT RM . In addition, brain circulating T M generated by i.v. infection failed to up-regulate CD103 and contained a lower percentage of D b -NP 396-404 -specific cells than bT RM generated by i.c. infection (Fig. 2 E) . Next, rLCMV memory mice with bT RM (i.c. + i.v. rLCMV co-infection) or without bT RM (i.v. rLCMV infection) were i.c. challenged with pathogenic WT LCMV (LCMVwt), which shared the immunodominant NP 396-404 epitope with rLCMV ( Fig. 2 F) . When analyzed 3 d later, rLCMV memory mice with bT RM exhibited significantly lower LCMV virus load in the brain than rLCMV memory mice with only circulating T M . This indicated that the generation of bT RM provided an advantage during reinfection.
CD103
+ and CD103 − bT RM persist in proximity to anatomical barriers and undergo homeostatic proliferation We next analyzed the spatial distribution of bT RM on brain sections by immunohistochemistry. bT RM were preferentially detected at brain surface structures, such as meninges and choroid plexus, around the ventricles or at anatomical borders between different brain regions (Fig. 3 A) . Only a small fraction of bT RM was in direct contact with vascular endothelium (14 ± 3%; Fig. 3 A) , but most bT RM localized in close proximity to vessels and brain surface structures, or both (Fig. 3 B) . Quantification of CD103 + and CD103 − bT RM in the analyzed areas did not reveal a correlation of CD103 expression with their localization (Fig. 3 C) . Interestingly, a consistent fraction of bT RM expressed proliferation marker Ki-67 (9 ± 1%) long after virus clearance (Fig. 3 D) . bT RM at brain surface structures expressed Ki-67 more frequently than bT RM localized in brain parenchyma (Fig. 3 E) . Previous studies have shown that IL-7-and IL-15-dependent longevity and homeostatic proliferation are maintaining central memory T cells by Stat5 signaling (Burchill et al., 2003; Willinger et al., 2005; Hand et al., 2010) . Indeed, a fraction of brain T cells showed Stat5 phosphorylation (26 ± 7%). Similarly to Ki-67 + T cells, we observed an increased proportion of P-Stat5 + T cells at brain surface structures (Fig. 3 F) . Using histocytometry (Fig. S2) , we could confirm that meninges contained a higher frequency of P-Stat5 + T cells than internal brain structures (Fig. 3 G) . Altogether, this indicates that Stat5-driven homeostatic proliferation contributes to the maintenance of the long-lived bT RM population preferentially at brain surface structures.
bT RM autonomously clear pathogenic LCMV challenge independently of circulating T M cells
To assess the contribution of circulating CD8 + T cells to virus control in the brain, we treated a group of rLCMV memory mice with anti-CD8 depleting antibody before LCMVwt i.c. challenge (Fig. 4 A) . rLCMV memory mice with bT RM and circulating T M contained significantly more T cells in the brain after challenge than mice with only circulating T M (Fig. 4 , B and C). As expected (Schenkel et al., 2013) , the numbers of brain-infiltrating T cells in the former group were significantly reduced when circulating T M were depleted. This indicated that about half of the brain CD8 + T cells after LCMVwt challenge of nondepleted mice originated from a recruitment of circulating T M , whereas the other half represented bT RM and their progeny. Furthermore, 47 ± 13% of bT RM expressed proliferation marker Ki-67 after LCMVwt i.c. challenge (Fig. 4 D) , indicating that a substantial fraction of bT RM entered the cell cycle upon antigen reencounter in the CNS. During LCMV i.c. challenge, both CD103 + and CD103 − bT RM expanded in similar proportions and showed equal potential for E and F) . Intriguingly, rLCMV memory mice with bT RM but lacking circulating T M , cleared virus from the brain equally efficiently as mice with both bT RM and circulating T M (Fig. 4 , C, G, and H). This suggested that recruitment of circulating T M was not required for bT RM -mediated virus clearance from the brain. Conflicting reports exist about T RM dependency on CD4 + T help in different organs (Jiang et al., 2012; Laidlaw et al., 2014) . To address the role of CD4 + T cells for the generation and function of bT RM , we depleted CD4 + T cells either during primary i.c. infection with rLCMV or performed a combined depletion of circulating CD4 + and CD8 + T cells during LCMVwt i.c. challenge. bT RM numbers, as well as bT RM -mediated rapid virus clearance during LCMVwt i.c. challenge, was not affected in the absence of CD4 + T cell help during bT RM generation or challenge with LCMVwt ( Fig. 5 , A-L). Furthermore, to exclude that recruited NK cells contribute to virus clearance, we depleted NK cells in addition to circulating T cells during LCMVwt i.c. challenge. However, virus clearance was unimpaired in animals containing bT RM but not circulating T and NK cells (Fig. 6 , A-E), demonstrating that LCMVwt control relied on bT RM .
bT RM -mediated virus clearance is dependent on presentation of cognate antigen Next, we aimed to investigate if presentation of cognate antigen is necessary or if bystander activation and expres- sion of antiviral genes in surrounding tissue is sufficient for bT RM -mediated viral clearance. Therefore, we challenged rLCMV memory mice with a genetically engineered LCMV variant (LCMV-NP N400S ), in which the MHC-I anchor residue of the immunodominant epitope NP 396-404 was mutated to abrogate MHC binding Fig. 7 A) , thus preventing MHC-I-restricted recognition of this virus by the vast majority of bT RM (Fig. 1 D and Fig. 2 E) . Accordingly, bT RM expansion was reduced when LCMV-NP N400S was used for challenge instead of LCMVwt (Fig. 7, B and C) . In further contrast to LCMVwt i.c. challenge, bT RM failed to clear the brain from LCMV-NP N400S within 3 d. This was evident in increased numbers of infected cells (Fig. 7 , B and D) and heightened LCMV RNA loads (Fig. 7 E) . Interestingly, antiviral interferon-induced transmembrane protein 3 (Ifitm3), a marker of T RM -induced antiviral state (Ariotti et al., 2014) , was similarly induced after infection with LCMVwt or LCMV-NP N400S , respectively (Fig. 7 F) . Furthermore, infection with either of the two viruses induced up-regulation of Granzyme B ( Data represent mean + SEM (n = 3-5 mice for unchallenged controls (−); n = 5-6 for mice challenged with LCMVwt i.c.) *, P < 0.05; **, P < 0.01, one-way ANO VA followed by Sidak's multiple comparisons test (B, G, and H); unpaired two-tailed Student's t test (D). One representative out of at least two independent experiments is shown (B-H). up-regulated GzmB (96 ± 1%) and Ki-67 (42 ± 3%) during i.c. challenge with LCMV-NP N400S (unpublished data).
bT RM -mediated rapid viral clearance depends on IFN-γ and perforin T cell-mediated viral clearance from the brain can be achieved by cytolytic, i.e., perforin or Fas-dependent mechanisms, as well as by noncytolytic, cytokine-dependent pathways (Griffin, 2003; Pinschewer et al., 2010; Herz et al., 2015) . To investigate cytokine production and cytotoxic potential of bT RM , we depleted memory mice of circulating CD8 + T cells and challenged them with LCMVwt i.c. (Fig. 8 A) . We analyzed CD107a surface exposure as indicator of degranulation of cytotoxic granule release and production of IL-2, IFN-γ, and TNF upon in vitro peptide stimulation (Fig. 8 B and not  depicted) . In the absence of LCMVwt challenge and without peptide restimulation, bT RM did not spontaneously produce detectable amounts of cytokines and did not degranulate. After LCMVwt i.c. challenge, bT RM exhibitedIFN-γ production (9.7 ± 1.5%) and surface exposure of CD107a (9.0 ± 0.5%) in the absence of further ex vivo stimulation. After peptide stimulation, most bT RM produced high amounts of IFN-γ in combination with surface exposure of CD107a, which was significantly higher in bT RM from LCMVwt i.c. challenged animals (59.0 ± 2.4%) than from unchallenged controls (36.4 ± 3.1%; Fig. 8 B) . In contrast, we detected comparably few bT RM that coproduced IL-2 or TNF, and we failed to detect expression of FasL on bT RM (unpublished data). Thus our analysis identified IFN-γ-producing bT RM with cytotoxic granule release as main effector cell population after LCMVwt i.c. challenge.
Considering IFN-γ as the main effector cytokine expressed by bT RM , we next tested bT RM function in IFN-γ knockout (GKO) mice. Of note, IFN-γ is dispensable for the clearance of primary infection with attenuated rLCMV (Pinschewer et al., 2010) and bT RM generation was not impaired in GKO mice (Fig. 8 C) . We depleted circulating CD8 + T cells in IFN-γ-deficient (GKO) and IFN-γ competent (control) rLCMV memory mice and subsequently challenged them with LCMVwt i.c. (Fig. 8, D-G) . Before LCMVwt i.c. challenge, GKO rLCMV memory mice displayed slightly higher bT RM numbers, but the fold expansion of bT RM after virus challenge was similar in GKO and control animals (Fig. 8, D and E) . This indicated that the cell-intrinsic reactivation capacity of bT RM was unimpaired in GKO mice. Conversely, the number of infected cells (Fig. 8, D and F) and LCMV RNA loads (Fig. 8 G) 3 d after LCMVwt i.c. challenge were significantly higher in GKO memory mice than in control memory mice.
Based on the notion that bT RM up-regulated the cytotoxic effector molecule Granzyme B after LCMV i.c. challenge (Fig. 7, G and H) , we next investigated whether cytolytic effector functions (Kägi et al., 1994) contributed to bT RMmediated virus clearance. We thus generated perforin-deficient (PKO) rLCMV memory mice and depleted circulating CD8 + T cells (Fig. 8, H-M) , as before (Fig. 8 A) . Perforin was dispensable for the generation of bT RM (Fig. 8 H) . Furthermore, after LCMVwt i.c. challenge, perforin-deficient bT RM showed unimpaired up-regulation of Granzyme B (Fig. 8 I) and secondary expansion (Fig. 8, J and K) . Nevertheless, PKO memory mice exhibited significantly higher numbers of infected cells (Fig. 8, J and L) and increased viral RNA loads (Fig. 8 M) than control memory mice. This demonstrated that bT RM cells exert rapid IFN-γ production and perforindependent cytotoxicity, both of which made essential contributions to the rapid control of viral infection in the brain. (Schenkel et al., 2013 . Here, we observed analogous findings in the brain (Fig. 4 B) , raising the possibility that bT RM could enhance immunopathological consequences of brain virus infection (Oehen et al., 1991) . We therefore investigated how the presence of bT RM impacts the disease after LCMVwt i.c. challenge. For that, we depleted LCMV-specific circulating T M in rLCMV memory mice using anti-CD8 antibody 6 wk before LCMVwt i.c. challenge (Fig. 9 A) . This timing enabled the reconstitution of the peripheral compartment with naive CD8 + T cells before LCMVwt challenge (unpublished data). Analogous to the experiment in which anti-CD8 depletion and challenge had been performed simultaneously (Fig. 4, B and D) , the presence of bT RM resulted in enhanced T cell numbers in the brain when circulating memory CD8 + T cells were present (Fig. 9, B and C) . However, irrespective of the presence or absence of circulating memory CD8 + T cells, brain LCMV loads as assessed 3 d after LCMVwt i.c. challenge were significantly reduced in mice with bT RM compared with mice with only circulating T M (Fig. 9 , B, D, and E). As expected (Oehen et al., 1991) , mice with only circulating T M did not develop disease, demonstrating that the observed peripheral virus-specific T M recall response can afford antiviral protection (Fig. 9 F) . Furthermore, circulating T M -depleted rLCMV memory mice without bT RM developed fatal choriomenigitis, which had kinetics comparable to unimmunized control mice. Most importantly, six out of seven rLCMV memory (B-E) n = 5 mice per group, (G-H) n = 4 mice per group, (I-L) n = 3 mice for naive WT mice infected with LCMVwt i.c. (white bars), n = 5-6 mice per group of rLCMV memory mice after LCMVwt i.c. challenge. *, P < 0.05; **, P < 0.01, one-way ANO VA with Tukey's multiple comparison test. One experiment was performed. Bars: 100 µm; (inset) 20 µm. mice with bT RM were protected from disease even though circulating T M cells had been depleted. This underscored the self-sufficient nature of bT RM -mediated antiviral protection. Next, we investigated whether bystander activation of bT RM (Fig. 7) was sufficient to protect animals from fatal immunopathology. We therefore depleted rLCMV memory mice of circulating T M and challenged them with either LCMVwt or LCMV-NP N400S i.c. after reconstitution of circulating CD8 + T cells. As expected, mice challenged with LCMV-NP N400S i.c. did not mount a D b -NP 396-404 -specific CD8 + T cell response, but developed a CD8 + T cell response specific for the D b -GP 33-41 epitope (data not shown), to which they had not been previously exposed (rLCMV does not encode for LCMV-GP 33-41 ). Unlike rLCMV memory mice challenged with LCMVwt i.c., challenge with LCMV-NP N400S i.c. resulted in the development of fatal choriomeningitis with disease kinetics comparable to unimmunized control mice (Fig. 9 G) . Altogether, this demonstrated that bT RM immunity was antigen-specific and provided rapid autonomous elimination of virus-infected cells from the brain and thereby protected from fatal immunopathological disease.
DIS CUS SION
The identification of T RM as a separate lineage of long-lived memory T cells has fundamentally reshaped our concepts of cell-mediated immunity to infection. With this study, we establish bT RM as an autonomous first line of adaptive immune defense against viral infection of the brain. bT RM were found after acute infection with rLCMV or a replication-deficient modified vaccinia virus strain in mice, attesting to the general validity of our findings. bT RM showed strong proliferative potential and protected against fatal viral infection in an organ-autonomous manner, independent of the recruitment of circulating CD8 + memory T cells. Similar to other nonlymphoid organs (Steinert et al., 2015) , CD69 + bT RM represented 90% of CD8 + T cells in the brain. Contrary to brain infection with vesicular stomatitis virus (Wakim et al., 2010) , we found in two independent models that CD103 was expressed only on a proportion of bT RM . This may be a result of differences in isolation and quantification methods, as has been described for other organs (Steinert et al., 2015) . We do not exclude the possibility that CD103 + and CD103 − bT RM may be functionally different; however both subsets persisted in stable proportions over time, exhibited an analogous preference for retention at surface-lining structures of the brain, and showed equal proliferative capacity upon reactivation. Although bT RM show very limited survival and proliferative capacity in vitro (Wakim et al., 2010) , they seem to possess self-renewing capacity in vivo and exhibit high proliferative capacity after reactivation. Similar to central memory T cells (Burchill et al., 2003; Willinger et al., 2005; Hand et al., 2010) , the population of long-lived bT RM seems to be maintained by Stat5-driven homeostatic proliferation, preferentially at brain surface structures, such as meninges and periventricular areas. However, the exact nature of a supposed T RM maintaining microenvironment near tissue surfaces that was also observed in other organs, i.e., in the skin (Gebhardt et al., 2009 ), remains to be investigated.
In naive hosts, the task of rapidly detecting invading pathogens and alerting the adaptive immune defense generally falls to the innate immune system (Iwasaki and Medzhitov, 2015) . The resulting secretion of antiviral effector cytokines, such as type I interferons, is crucial to limiting virus spread until adaptive immune responses are induced and can accomplish viral clearance (McNab et al., 2015) . T RM from peripheral organs other than the brain have been described to subserve a similar immunological function, i.e., to alert circulating T cell subsets to invading pathogens and to induce antiviral genes in the tissue surrounding the site of initial infection (Ariotti et al., 2014; . These functions were reported to be largely dependent on inflammatory cytokines, such as IFN-γ. Similar to T RM from other organs, we show here that bT RM share the capacity to secrete IFN-γ upon antigen reencounter. However, they largely do that in combination with the release of cytotoxic granules, and perforin-mediated cytotoxicity was essential for rapid bT RM -mediated virus control. One may thus speculate that IFN-γ-deficient bT RM fail to provide sufficient noncytolytic antiviral function, or fail to prepare the site of infection for lytic effector function as a result of impaired up-regulation of MHC I expression on infected cells (Bergmann et al., 2003) . Whereas both possibilities are not mutually exclusive and can contribute to the observed outcome, our data strongly suggest that a direct interaction of bT RM with infected cells rather than a generalized antiinflammatory state is necessary for bT RM -mediated rapid viral elimination. This conclusion is based on our observation that bT RM can be activated in a bystander manner, i.e., in the absence of cognate antigen and solely as the result of the inflammatory environment (Kohlmeier et al., 2010; Soudja et al., 2012; Raué et al., 2013) , yet under such circumstances fail to rapidly control the virus. This does not, however, exclude the possibility that bystander activation may contribute to a viral load reduction in the brain. Furthermore, depending on the pathogen type and infection scenario, bT RM -driven induction of IFN-γ response genes may be sufficient to limit early pathogen spread or even to cleanse viruses from nonrenewable cells such as neurons (Griffin, 2003; Herz et al., 2015) .
Neurotropic viruses of hematogenous origin frequently infect the CNS secondary to systemic infection. Neuroinvasion typically occurs through the brains outer or inner linings (McGavern and Kang, 2011) , namely the meninges or the ependyma, to subsequently spread into the brain parenchyma. The resulting inflammation manifests as meningitis or even encephalitis and can be life-threatening (Gilden et al., 2007) . Our model of intracranial rLCMV immunization recapitulates the spread from the brain linings into the parenchyma albeit it does not reproduce neuroinvasion secondary to systemic infection. Conversely, its attenuated behavior enabled us to study solid bT RM immunity without the caveats of life-threatening complications from primary brain infection.
Although we noted a protective function of bT RM in infection, T RM -mediated activation and recruitment of inflammatory cells to the site of infection can, however, also have detrimental effects such as those described in the context of skin contact hypersensitivity (Gaide et al., 2015) . In organs with limited regenerative capacity, such as the CNS, excessive inflammation can induce collateral damage (immunopathology). In this regard, severe immunopathological disease is one of the most dangerous complications of viral infections in the brain, and depending on pathogen loads, circulating T M can even accentuate disease rather than prevent it (Oehen et al., 1991) . Therefore, not only infections of the CNS but also the resulting immune responses must be tightly controlled. The functioning of bT RM as a border patrol, which rapidly detects and autonomously eliminates the first few virus-infected cells, thus bypasses the need for antigen drainage to lymph nodes and reactivation of T M cells inside secondary lymphoid organs. It has been shown for other organs that T RM cells use a continuous migratory behavior, enabling few cells to survey large organ structures and readily detect their cognate antigen (Ariotti et al., 2012) . The positioning and preferential maintenance of bT RM at surface-associated brain structures and in proximity to vessels as described in this study therefore matches the specific immunological challenge and need of the brain to limit viral spread from the circulation and brain linings into the parenchyma and to rapidly eliminate the initially infected cells. Thereby, bT RM can balance pathogen control against excessive inflammation.
Based on the present observations, we propose to adapt the concept of immunological privilege of the brain. With identification of the bT RM compartment, the brain undoubtedly maintains powerful immunological forces to fight recurrent microbial intruders. This observation stands in stark contrast to the several layers of immunomodulatory mechanisms, including constitutively low expression of MHC molecules (Neumann et al., 1995) , which are in place to limit inflammation in the brain (Galea et al., 2007) . Thus, pathogens that have previously invaded the brain appear to be specifically excluded from this immunological privilege and are instead rapidly and efficiently eliminated by bT RM . It is tempting to speculate that bT RM immunity must be particularly potent because the blood-brain barrier prevents antibody access to the brain, and thus is largely excluding this organ from protection by the humoral arm of immunological memory.
MAT ERI ALS AND MET HODS
Mice. C57BL/6 WT, IFN-γ deficient (GKO; Dalton et al., 1993) , perforin-deficient (PKO; Kägi et al., 1994) , OT-1 TCR transgenic (Hogquist et al., 1994) , and P14 TCR (Pircher et al., 1989 ) transgenic mice were bred and lodged under P2 conditions in the animal facilities of the University Medical Centre of Geneva and Munich. Sex-and agematched mice between 6 and 12 wk of age were used for experiments. All animal experiments were authorized by the cantonal veterinary office of Geneva and performed in agreement with the Swiss law for animal protection.
Virus infection. Recombinant LCMV strains were generated according to established methods (Pinschewer et al., 2003) . The following virus strains were used: recombinant LCMV encoding for the glycoprotein of vesicular stomatitis virus (VSV) instead of its own glycoprotein (rLCMV/ INDG, abbreviated rLCMV throughout); rLCMV encoding for a chimeric glycoprotein of VSV containing the leader sequence of LCMV glycoprotein with the GP33 epitope of LCMV (rLCMV-GP33); and recombinant LCMV encoding for OVA (rLCMV-OVA). Genetically engineered WT LCMV (LCMVwt, Armstrong strain) and LCMV mutant virus (LCMV-NP N400S ) lacking the CTL-specific epitope NP 396-404 were generated as described previously . Viruses were produced, titrated, and administered to mice as previously described (Flatz et al., 2006) . For transient virus infection in the brain, 10 4 PFU rLCMV was administered i.c. i.v. infected control animals were injected i.c. with vehicle. Memory and naive mice were challenged with 10 3 PFU LCMVwt (Armstrong strain) i.c. Incidence of choriomenigitis was determined by occurrence of general malaise and hind limb cramps, and severely diseased animals were immediately sacrificed. Brain virus load was analyzed by quantitative RT-PCR for LCMV-NP (McCausland and Crotty, 2008) . Brain total RNA was isolated from deparaffinized tissue sections using RNeasy Mini kit (QIA GEN), cDNA was synthesized using iScript cDNA synthesis kit (Bio-Rad Laboratories), and relative expression of LCMV S segment was determined against GAP DH as housekeeping gene (QIA GEN) using iQ SYBR Green Supermix (BioRad Laboratories).
Replication-deficient MVA-OVA was generated as described previously (Staib et al., 2004) . 2 × 10 6 IU MVA-OVA was administered intrathecally (i.th.) as previously described (Rothhammer et al., 2014) . In some experiments, OT-1 or P14 TCR transgenic CD8 + T cells were adoptively transferred into naive C57BL/6 mice 24 h before i.c. or i.th. infection. + T cells in rLCMV memory mice were reduced from 1.4 ± 0.3% to 0.06 ± 0.02%, which was not significantly above technical background in uninfected naive control mice (0.005 ± 0.004%).
Intravascular staining of CD8
+ T cells. Mice were injected i.v. with 3 µg PE-labeled anti-CD8b (YTS156.7.7) according to previously described protocols (Anderson et al., 2014) . 3 min later, peripheral blood samples were taken, and mice were anesthetized and perfused with PBS. Brains were dissected and processed immediately (<10 min after antibody injection) for leukocyte isolation (see Flow cytometry).
Immunohistochemistry. For immunohistochemical bright field staining of mouse tissue, brains and spleen were prepared and fixed in Hepes-glutamic acid buffer-mediated organic solvent protection effect (HOPE, DCS Innovative) fixative as previously described (Bergthaler et al., 2007) and embedded in paraffin. Upon inactivation of endogenous peroxidases, tissue sections were incubated with rat anti-mouse CD8a (YTS169.4) or rat anti-LCMV NP (VL-4; Battegay et al., 1991) . Bound primary antibodies were visualized with biotin-labeled anti-rat antibody and streptavidin-peroxidase staining method using polymerized 3,3′-diaminobenzidine (all reagents from Dako; haemalaun counterstaining of nuclei).
For immunofluorescence staining of mouse tissue, cryosections were fixed with 2% PFA for 5 min and unspecific binding blocked (PBS/1% BSA/2% FCS). Sections were incubated with FITC-labeled Armenian hamster anti-mouse CD103 (2E7) and rat anti-mouse CD8a (YTS169.4), followed by rabbit anti-FITC (Invitrogen) antibody. Bound antibodies were visualized with Alexa Fluor 488-labeled goat anti-rabbit and Cy3-labeled goat anti-rat secondary antibodies (Jackson ImmunoResearch Laboratories). Nuclei were stained with DAPI (Invitrogen).
For immunofluorescence staining of paraffin embedded tissue, mice were transcardially perfused with 4% PFA. After antigen retrieval and unspecific binding blocking (PBS/10% FCS), sections were incubated with rat anti-human CD3 (CD3-12), rat anti-mouse CD8 (clone 4SM15), goat antimouse CD69 (AF2386), rabbit anti-VWF (ab6994), rabbit anti-Ki-67 (ab66155), and rabbit anti-phospho-Stat5 (tyr694, C71E5). Bound antibodies were visualized with Alexa Fluor 488 or Alexa Fluor 568 goat anti-rabbit tyramide signal (TSA) amplification (Thermo Fisher Scientific), Cy2-or Cy3-labeled goat-anti-rat, or Cy5-labeled goat anti-rabbit secondary antibodies (Jackson ImmunoResearch Laboratories). Nuclei were stained with DAPI (Invitrogen).
Immunostained sections were scanned using Pannoramic Digital Slide Scanner 250 FLA SH II (3DHI STE CH) in 200× magnification. Quantifications were performed manually using Pannoramic Viewer software (3DHI STE CH) blinded to the experimental setup of histological samples. For representative images, white balance was adjusted and contrast was linearly enhanced using the tools levels, curves, brightness, and contrast in Photoshop CS6 (Adobe). For histocytometry analysis, fluorescence-immunostained brain sections were scanned using a high-dynamic range camera (16 bit).
For histocytometry and density plots, CD3 + or CD8 + cells, respectively, were detected on scanned slides applying a custom-programmed script in Cognition Network Language (Definiens Developer XD software). For analysis of distance, a grayscale distance map was computed to encode the closest distance of each detected CD3 + or CD8 + cell to the brain surface and vessels (detected by von-Willebrand Factor staining) and mean values of distance maps were extracted. For histocytometry, each CD3 + cell size (area), as well as mean and max grayscale values for CD3, P-Stat5, and DAPI signals, were extracted. The resulting CSV files were converted to .fcs format using an open source program (FlowJo). The converted file was analyzed using FlowJo X. Co-staining of anti-CD3 and anti-phospho-Stat5 was gated based on control staining without primary P-Stat5 antibody. Peripheral blood samples and splenocytes were collected in FACS-Buffer (10% FCS, 10 mM EDTA, and 0.01% NaN 3 in PBS). Peripheral blood erythrocytes were lysed using BD FACS lysing solution (BD). For the preparation of brain leukocytes, mice were anesthetized and transcardially perfused with PBS. Brains were minced, digested with Collagenase/DNaseI (Roche), and homogenized using 70-µm cell strainers (BD). Leukocytes were separated using a discontinuous Percoll gradient (30%/70%). Surface staining was performed with directly labeled antibodies and tetramers in FACS buffer. Isolated CD8 + T cell numbers were quantified using TruCOU NT tubes (BD) or AccuCheck Counting Beads (Invitrogen) as previously described (Steinbach et al., 2013) . Intracellular staining of Ki-67 was performed using FoxP3/Transcription Factor Staining Buffer Set (eBioscience) according to manufacturer's instructions. For ex vivo staining of Granzyme B, cells were fixed and permeabilized using commercial permeabilization buffer set (BioLegend). To assess degranulation and intracellular cytokine production, brain leukocytes were cultured for 5 h in the presence of 5 µg/ml FITC-labeled anti-CD107a antibody, monensin, and brefeldin A. Cells were stimulated in vitro with 1 µM NP [396] [397] [398] [399] [400] [401] [402] [403] [404] peptide or left unstimulated, respectively. Cells were harvested and dead cells were excluded from the analysis using Zombie NIR Fixable Viability kit (BioLegend). Cells were fixed and permeabilized using commercial permeabilization buffer set (BioLegend), followed by intracellular staining for cytokines, respectively. Flow cytometric samples were acquired on a Gallios cytometer (Beckman-Coulter) equipped with three lasers (blue, 488 nm; red, 633 nm; and violet, 405 nm) using appropriate filter sets and compensation controls. Gates were assigned according to appropriate control populations. A CyAn ADP analyzer (Beckman-Coulter) was used for experiments involving MVA-OVA.
Statistical analysis. Analysis was performed using GraphPad 6.0 (Prism). To assess significant differences between single measurements of two groups, unpaired or paired two-tailed Student's t test was used, whereas differences between single measurements of more than two groups was assessed by oneway ANO VA, followed by post hoc analyses of selected pairs of datasets using Sidak's multiple comparisons test or all pairs of datasets using Tukey's multiple comparisons test to control for multiple comparisons. To assess significant differences between groups with multiple measurements, two-way repeatedmeasures ANO VA was performed followed by Dunnet's multiple comparisons test against control group. For comparison of disease incidence, Log rank (Mantel-Cox) test was used. P < 0.05 was considered significant, and P < 0.01 was considered highly significant, whereas P > 0.05 was considered statistically not significant.
Online supplemental material. Fig. S1 shows the gating strategy used for analysis of brain-derived leukocytes. Fig. S2 shows the histocytometry data processing and the gating strategy. Online supplemental material is available at http :// www .jem .org /cgi /content /full /jem .20151916 /DC1. 
